Mesalamine
Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa (mesalamine) is a small molecule pharmaceutical. Mesalamine was first approved as Apriso on 1987-12-24. It is used to treat proctitis, sigmoid diseases, and ulcerative colitis in the USA. It is known to target peroxisome proliferator-activated receptor gamma. Pentasa's patents are valid until 2030-05-01 (FDA).
| Trade Name | Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa |
|---|---|
| Common Name | Mesalamine |
| Indication | proctitis, sigmoid diseases, ulcerative colitis |
| Drug Class | Anti-inflammatory agents (salicylic acid derivatives) |
